Minnesota HF2275 modifies insulin manufacturer registration fees, setting an annual fee of $100,000 with exemptions for low-volume sellers.
Minnesota HF2275 amends the registration fee for insulin manufacturers in the state. It sets an annual registration fee of $100,000 for all manufacturers selling or delivering insulin within Minnesota. However, manufacturers can request an exemption if their sales of insulin in Minnesota account for less than five percent of their total gross revenue from insulin sales. The board will notify manufacturers of this requirement starting November 1, 2024, and annually thereafter. The commissioner of health will assist the board with technical support using available data sources.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.